Publications
- ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients2016 | Second Faculty of Medicine
- ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients2016 | Second Faculty of Medicine
- Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients2016 | Second Faculty of Medicine
- Ganciclovir treatment failure in adult allogeneic hematopoietic stem cell transplant recipients with cytomegalovirus infection - a single centre experience2015 | Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Post-mortem analysis of Candida albicans breakthrough infection during echinocandin treatment in haematopoietic stem cell transplant recipient2014 | Second Faculty of Medicine
- Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation2014 | Second Faculty of Medicine
- Deficit of GATA-2 transcription factor: new immunodeficiency syndrome with broad phenotype. First patients diagnosed in the Czech Republic and review of the literature2013 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport, Faculty of Medicine in Pilsen
- Prevalence of chromosomally integrated HHV-6 in patients with malignant disease and healthy donors in the Czech Republic2013 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Physical Education and Sport
- Diagnostics, treatment and prophylaxis of EBV infection/reaction/associated lymphoproliferation in patients with hematological malignancies - CELL recommendations2013 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- CMV infection in immunocompromised patients, epidemilogy, risk factors and clinical symptoms2013 | Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
Loading network view...